Translational Research in Surgical Oncology

描述（由申请人提供）：超过一百万美国人将遭受 每年有大约一半的人死于癌症， 疾病 尽管在预防癌症方面做出了重大努力，但有效的早期诊断 非转移性疾病的治疗仍然是现代癌症的标志。 有效的癌症管理。 手术仍然是主要的诊断方法， 治疗癌症的方法，以及 手术技术（如光纤和放射性核苷酸 正常和病变组织的可视化以及小型化和 机器人控制的仪器），有助于改善护理的 癌症患者。 尽管如此，这是一种对生物学基础的理解， 疾病以及癌症的有效诊断和治疗管理 在多学科背景下，将带来最大的进步， 未来十年 在当前的发现时代， 对外科医生进行癌症生物学基础方面的教育和培训， 史无前例 癌症遗传学、细胞生物学和免疫学进展 为基础、转化和临床研究提供重要机会 在癌症研究中。 正如美国外科医生学会肿瘤学小组 重新定位到杜克，一个重要的机会，以加强培训， 存在外科医生的转化研究。 这种教育和 培养未来的外科科学家和领导者提供了一个 C O M pelling important for this application for a training grant in 外科肿瘤学的转化研究。

DESCRIPTION (provided by applicant): Over one million Americans will suffer from cancer every year, and approximately half of them will die from the disease. Despite major efforts to prevent cancer, effective early diagnosis and treatment of non-metastatic disease remains the hallmark of modern effective cancer management. Surgery persists as a major diagnostic and therapeutic modality for the management of cancer, and advances in the technology of surgical technique (such as fiber-optic and radio-nucleotide visualization of normal and diseased tissue and the miniaturization and robotic control of instruments) have contributed to the improved care of the cancer patient. Nonetheless, it is an understanding of the biologic basis of the disease, and the effective diagnostic and therapeutic management of cancer within a multidisciplinary context that will bring the greatest advances over the next decade. In the current era of discovery, the opportunities for the education and training of surgeons in the biologic basis of cancer is unprecedented. The advances in cancer genetics, cell biology and immunology provide important opportunities for basic, translational and clinical studies in cancer research. As the American College of Surgeons Oncology Group has r e l ocated to Duke, an important opportunity to enhance training in translational research for surgeons exists. This opportunity to educate and train future generations of surgical scientists and leaders provided a c o m pelling imperative for this application for a training grant in translational studies in surgical oncology.